Teva > Corporate Officers

Corporate Officers

	Shlomo Yanai President and Chief Executive Officer

Amir Elstein
Executive Vice President, Global Pharmaceutical Resources

Isaac (Ika) Abravanel
Corporate Vice
President - Human Resources

Chaim Hurvitz
Group Vice President - International

Dr. Itzhak Krinsky
Corporate Vice
President - Business Development

Moshe Manor
Group Vice President - Global Innovative Resources

William S. Marth
President and Chief Executive Officer Teva North America

Dr. Gerard Van Odijk
Group Vice President Europe, and President and CEO Teva Pharmaceuticals
Europe B.V.

Eli Shohet
Vice President CEE

Dan S. Suesskind
Chief Financial Officer

Dr. Ben-Zion Weiner
Chief R&D Officer

Jacob Winter
Group Vice President - Global Generic Resources

Aharon Yaari
Group Vice President - Global API Division

Yehuda Arad
Vice President - Safety and Environment

Dr. Shmuel Ben Zvi
Vice President - Planning, Economics & IT

Doron Blachar
Vice President - Finance

Rodney Kasan
Vice President and Chief Technology Officer

Dr. Rivka Riven Kreitman
Senior Vice President - Global Innovative R&D

Michael Netz
Vice President - Global Innovative Products Division

Dr. Shosh Neumann
Vice President - Product Portfolio Management

Christopher Pelloni
Vice President - Global Generic R&D

Dr. David Reisman
Vice President - Israel Pharmaceutical Operations

Dr. Aharon Schwartz
Vice President - Strategic Business Planning and New Ventures

Judith Vardi
Vice President - Israel Pharmaceutical Sales

Ron Grupel
Internal Auditor

Uzi Karniel
General Counsel and Corporate Secretary